Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Cigna Corp. | 32 | 0 | 1 | 0 | €244.30 | €286.34 | 17.209% |
| Edwards Lifesciences Corp. | 31 | 0 | 7 | 0 | €77.60 | €85.42 | 10.077% |
| Thermo Fisher Scientific Inc. | 30 | 0 | 1 | 0 | €513.60 | €538.69 | 4.885% |
| Arrowhead Pharmaceuticals Inc. | 30 | 0 | 8 | 0 | €75.82 | €85.20 | 12.365% |
| iRhythm Technologies Inc | 29 | 0 | 3 | 0 | €107.00 | €171.04 | 59.850% |
| United Therapeutics | 29 | 1 | 2 | 0 | €466.00 | €541.88 | 16.282% |
| WAVE Life Sciences Ltd | 28 | 0 | 5 | 0 | €5.15 | €19.45 | 277.629% |
| BioMarin Pharmaceutical Inc. | 28 | 0 | 2 | 0 | €55.16 | €73.07 | 32.477% |
| MannKind Corp. | 27 | 0 | 2 | 0 | €3.55 | €7.78 | 119.107% |
| Stryker Corp. | 27 | 0 | 5 | 0 | €293.20 | €350.80 | 19.644% |
| Acadia Pharmaceuticals | 27 | 0 | 3 | 0 | €25.28 | €29.31 | 15.960% |
| Humana Inc. | 32 | 7 | 8 | 0 | €334.00 | €186.51 | -44.158% |
| Ultragenyx Pharmaceutical Inc. | 25 | 0 | 2 | 0 | €23.54 | €50.82 | 115.888% |
| Merck & Co. Inc. | 25 | 0 | 5 | 0 | €111.22 | €122.14 | 9.817% |
| Incyte Corp. | 25 | 1 | 7 | 0 | €104.30 | €114.79 | 10.061% |
| Charles River Labs Intl | 24 | 0 | 3 | 0 | €231.30 | - | - |
| Elanco Animal Health Inc. | 24 | 0 | 2 | 0 | €19.13 | €25.33 | 32.424% |
| Haemonetics Corp. | 23 | 0 | 4 | 0 | €76.00 | €75.99 | -0.012% |
| AnaptysBio Inc | 23 | 0 | 0 | 0 | €47.14 | €60.59 | 28.521% |
| Halozyme Therapeutics Inc. | 24 | 1 | 4 | 0 | €89.18 | €91.12 | 2.174% |
| Teva Pharmaceutical Industries Ltd ADR | 23 | 0 | 1 | 0 | €30.60 | €34.74 | 13.540% |
| Ocular Therapeutix Inc. | 25 | 2 | 1 | 0 | €7.95 | €17.90 | 125.215% |
| Alkermes plc | 23 | 1 | 2 | 0 | €42.63 | €46.86 | 9.925% |
| Verastem Inc. | 23 | 1 | 0 | 0 | €5.83 | €15.61 | 167.516% |
| Krystal Biotech | 22 | 0 | 3 | 0 | €282.20 | €272.02 | -3.608% |